Skip to content
healthcare.dev
Get a free key

Neostigmine methylsulfate

NDC 70700-171, Neostigmine methylsulfate, injection, from Xiromed LLC.

Product NDC
70700-171
Status
Listed
Labeler
Xiromed LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212968
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70700-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE.5 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
70700-171-22707000171221 VIAL, MULTI-DOSE in 1 CARTON (70700-171-22) / 10 mL in 1 VIAL, MULTI-DOSE
70700-171-237070001712310 VIAL, MULTI-DOSE in 1 CARTON (70700-171-23) / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/801225d9-eb71-dbef-e860-4caf7a22f27f

Use it

Look up 70700-171 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70700-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70700-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.